东方海洋：全资子公司艾维可生物科技有限公司的降钙素原（PCT）测定试剂盒（荧光免疫层析法）获得医疗器械注册证

Core Viewpoint - The company announced that its wholly-owned subsidiary, Aiveke Biotechnology Co., Ltd., has received a medical device registration certificate from the Shandong Provincial Drug Administration for its self-developed procalcitonin (PCT) assay kit, which is approved for market launch [1] Group 1 - The PCT assay kit is designed for the quantitative detection of procalcitonin levels in human serum, plasma, and whole blood samples [1] - The product has not yet been put into production, and its actual sales will be influenced by market expansion efforts and actual market demand [1] - The impact of Aiveke Biotechnology Co., Ltd. on the company's performance this year has been minimal, and future impacts remain uncertain [1]